Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 2104 entries
Sorted by: Best Match Show Resources per page
Reoxygenation between radiotherapy fractions in an experimental osteosarcoma.

European journal of cancer & clinical oncology

van Putten LM, de Ruiter J, van der Vecht B.
PMID: 3868622
Eur J Cancer Clin Oncol. 1985 Dec;21(12):1561-2. doi: 10.1016/0277-5379(85)90254-8.

No abstract available.

Prevention of cisplatin nephrotoxicity.

European journal of cancer & clinical oncology

De Broe ME, Wedeen RP.
PMID: 3780808
Eur J Cancer Clin Oncol. 1986 Sep;22(9):1029-31. doi: 10.1016/0277-5379(86)90001-5.

No abstract available.

Hodgkin's disease in Osaka, Japan (1964-1985).

European journal of cancer & clinical oncology

Aozasa K, Ueda T, Tamai M, Tsujimura T.
PMID: 3780817
Eur J Cancer Clin Oncol. 1986 Sep;22(9):1117-9. doi: 10.1016/0277-5379(86)90016-7.

In the present study, 96 cases of HD selected from 937 cases of malignant lymphomas in Osaka, Japan were reviewed to evaluate a time trend of HD. The results showed that, during the periods from 1964-74 to 1975-85, (1)...

Endocrine therapy of breast cancer.

European journal of cancer & clinical oncology

Harmsen HJ, Porsius AJ.
PMID: 3046948
Eur J Cancer Clin Oncol. 1988 Jul;24(7):1099-116. doi: 10.1016/0277-5379(88)90116-2.

The aim of this literature study is to evaluate the various endocrine drugs used in the treatment of breast cancer in order to compare their therapeutic efficacy. Hormone-dependent metastasized breast cancer of post-menopausal women can be treated with four...

Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA).

European journal of cancer & clinical oncology

Scapa E, Thomas P, Loewenstein MS, Zamcheck N.
PMID: 2933260
Eur J Cancer Clin Oncol. 1985 Sep;21(9):1037-42. doi: 10.1016/0277-5379(85)90287-1.

Fifty-one patients (16 with malignant extrahepatic biliary obstruction, ten with benign extrahepatic biliary obstruction, eight with alcoholic liver disease, five with viral hepatitis and 12 with liver metastases) and 19 adult healthy controls were studied with determinations of beta-N-acetyl...

Evaluating and designing cancer chemotherapy treatment using mathematical models.

European journal of cancer & clinical oncology

Birkhead BG, Gregory WM, Slevin ML, Harvey VJ.
PMID: 3956557
Eur J Cancer Clin Oncol. 1986 Jan;22(1):3-8. doi: 10.1016/0277-5379(86)90335-4.

No abstract available.

Circadian rhythm in tolerance of mice for the new anthracycline analog 4'-O-tetrahydropyranyl-adriamycin (THP).

European journal of cancer & clinical oncology

Levi F, Mechkouri M, Roulon A, Bailleul F, Lemaigre G, Reinberg A, Mathe G.
PMID: 4076288
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1245-51. doi: 10.1016/0277-5379(85)90022-7.

A statistically significant circadian rhythm in tolerance of 226 male B6D2F1 mice synchronized with LD 12:12 for 4'-O-tetrahydropyranyl-adriamycin (THP) was demonstrated. Four intravenous dosages (18, 25, 32 and 40 mg/kg) and six different dosing times (3, 7, 10, 14,...

VIIIth meeting of the European Association for Cancer Research (EACR). Seminar reports and meeting abstracts. Bratislava, Czechoslovakia, 13-15 May 1985.

European journal of cancer & clinical oncology

[No authors listed]
PMID: 4076296
Eur J Cancer Clin Oncol. 1985 Nov;21(11):1357-431.

No abstract available.

Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice.

European journal of cancer & clinical oncology

Brünner N, Spang-Thomsen M, Vindeløv L, Wolff J, Engelholm SA.
PMID: 4076295
Eur J Cancer Clin Oncol. 1985 Nov;21(11):1349-54. doi: 10.1016/0277-5379(85)90316-5.

A study was made of the in vivo effect of the anti-oestrogen tamoxifen on the growth and cell cycle kinetics of the oestrogen and progesterone receptor-positive T61 human breast carcinoma and of the oestrogen and progesterone receptor-negative T60 human...

Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.

European journal of cancer & clinical oncology

de Muralt B, de Tribolet N, Diserens AC, Stavrou D, Mach JP, Carrel S.
PMID: 2985398
Eur J Cancer Clin Oncol. 1985 Feb;21(2):207-16. doi: 10.1016/0277-5379(85)90175-0.

The reactivity spectrum of three monoclonal antibodies (Mabs) to human malignant glioma, five Mabs to melanomas and one Mab anti-HLA-DR was investigated by an indirect antibody binding radioimmunoassay on a panel of cells derived from 60 glioma lines, including...

Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine).

European journal of cancer & clinical oncology

Burtin C, Noirot C, Scheinmann P, Galoppin L, Sabolovic D, Bernard P.
PMID: 3356203
Eur J Cancer Clin Oncol. 1988 Feb;24(2):161-7. doi: 10.1016/0277-5379(88)90247-7.

In a randomized study 31 patients with advanced cancer disease in whom classical anticancer therapy had been abandoned received a daily combination of subcutaneous histamine and oral H2-antihistaminics. In 27 patients, treatment induced a marked clinical improvement as shown...

Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif.

European journal of cancer & clinical oncology

Schlumberger M, Travagli JP, Fragu P, Gardet P, Lumbroso J, Parmentier C.
PMID: 3356217
Eur J Cancer Clin Oncol. 1988 Feb;24(2):345-50. doi: 10.1016/0277-5379(88)90278-7.

The recent introduction of sTSH assays allows for a definite control of the inhibition of TSH secretion. Clinical examination and serum thyroid hormone measurements are necessary to obviate hyperthyroidism. Relapses may occur after decades of apparent complete remission. Follow-up...

Showing 1 to 12 of 2104 entries